• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本非酒精性脂肪性肝病的特征性表现,重点关注年龄、性别和体重指数的作用。

Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.

机构信息

Department of Internal Medicine and Gastroenterology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.

Department of Internal Medicine and Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Gut Liver. 2020 Sep 15;14(5):537-545. doi: 10.5009/gnl19236.

DOI:10.5009/gnl19236
PMID:31887811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7492496/
Abstract

This review provides an update on the characteristics of nonalcoholic fatty liver disease (NAFLD), with a focus on the effects of age, sex, and body mass index. Age is a risk factor for NAFLD progression; however, extremely old patients have unique features, namely, the associations between metabolic comorbidities and NAFLD are weaker and NAFLD is not a risk factor for mortality. The prevalence of NAFLD is higher in men than in premenopausal women, whereas the reverse is true after menopause. Thus, before menopause, estrogen may have protective effects against NAFLD. Our hospital data showed that over 25% of male patients with NAFLD and almost 40% of female patients with NAFLD, especially elderly patients, were nonobese. Although histological steatosis and activity were associated with body mass index, the prevalence of nonalcoholic steatohepatitis was not. The prevalence of advanced fibrosis showed a significant sex difference. Advanced fibrosis was significantly more frequent among severely obese men but the prevalence was lower among severely obese women. This difference could be because a substantial proportion of severely obese women were premenopausal; thus, estrogen may have much stronger effects on the development of fibrosis than on obesity. Further studies are required to develop tailored management strategies.

摘要

这篇综述介绍了非酒精性脂肪性肝病(NAFLD)的特征,重点介绍了年龄、性别和体重指数的影响。年龄是 NAFLD 进展的一个危险因素;然而,非常高龄的患者具有独特的特征,即代谢合并症与 NAFLD 的相关性较弱,并且 NAFLD 不是死亡的危险因素。男性的 NAFLD 患病率高于绝经前女性,而绝经后则相反。因此,绝经前,雌激素可能对 NAFLD 具有保护作用。我们医院的数据显示,超过 25%的男性 NAFLD 患者和约 40%的女性 NAFLD 患者,尤其是老年患者,是非肥胖者。虽然组织学脂肪变性和活动与体重指数有关,但非酒精性脂肪性肝炎的患病率与体重指数无关。晚期纤维化的患病率存在显著的性别差异。严重肥胖的男性中晚期纤维化明显更为常见,但严重肥胖的女性中晚期纤维化的患病率较低。这种差异可能是因为大量严重肥胖的女性处于绝经前;因此,雌激素对纤维化的发展可能比对肥胖的影响更强。需要进一步的研究来制定有针对性的管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/b925c85bd20d/GNL-14-537-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/0ae4719d5b3d/GNL-14-537-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/9a0352c7b4fc/GNL-14-537-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/96dd52b17154/GNL-14-537-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/70e8bdd41289/GNL-14-537-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/b925c85bd20d/GNL-14-537-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/0ae4719d5b3d/GNL-14-537-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/9a0352c7b4fc/GNL-14-537-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/96dd52b17154/GNL-14-537-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/70e8bdd41289/GNL-14-537-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3882/7492496/b925c85bd20d/GNL-14-537-f5.jpg

相似文献

1
Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.日本非酒精性脂肪性肝病的特征性表现,重点关注年龄、性别和体重指数的作用。
Gut Liver. 2020 Sep 15;14(5):537-545. doi: 10.5009/gnl19236.
2
Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign.日本瘦型非酒精性脂肪性肝炎患者的特征:并非少见且并非总是良性。
J Gastroenterol Hepatol. 2019 Aug;34(8):1404-1410. doi: 10.1111/jgh.14585. Epub 2019 Jan 15.
3
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
4
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.台湾地区体重指数对非酒精性脂肪性肝病临床病理特征的影响。
J Gastroenterol Hepatol. 2022 Oct;37(10):1901-1910. doi: 10.1111/jgh.15936. Epub 2022 Jul 13.
5
Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.非肥胖非酒精性脂肪性肝病中非酒精性肝炎和显著纤维化的预测因素。
Liver Int. 2019 Feb;39(2):332-341. doi: 10.1111/liv.13983. Epub 2018 Oct 27.
6
Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh.孟加拉国非肥胖型非酒精性脂肪性肝病患者的临床、人体测量学、生化及组织学特征
Indian J Gastroenterol. 2014 Sep;33(5):452-7. doi: 10.1007/s12664-014-0488-5. Epub 2014 Jul 15.
7
Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.衰老也是绝经前女性非酒精性脂肪性肝病的一个风险因素。
World J Gastroenterol. 2012 Jan 21;18(3):237-43. doi: 10.3748/wjg.v18.i3.237.
8
Nonobese Fatty Liver Disease.非肥胖性脂肪肝疾病。
Clin Gastroenterol Hepatol. 2017 Apr;15(4):474-485. doi: 10.1016/j.cgh.2016.08.028. Epub 2016 Aug 28.
9
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.非酒精性脂肪性肝病瘦患者的特征:高血红蛋白水平的潜在作用。
Scand J Gastroenterol. 2015 Mar;50(3):341-6. doi: 10.3109/00365521.2014.983160. Epub 2014 Dec 26.
10
Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.芳香酶抑制剂与绝经后早期乳腺癌患者新发非酒精性脂肪性肝病:一项倾向评分匹配队列研究。
Oncologist. 2019 Aug;24(8):e653-e661. doi: 10.1634/theoncologist.2018-0370. Epub 2019 Jan 24.

引用本文的文献

1
The relationship between dietary sodium intake and all-cause mortality in patients with non-alcoholic fatty liver disease: a cohort study from NHANES 2003-2018.非酒精性脂肪性肝病患者饮食钠摄入量与全因死亡率之间的关系:一项来自2003 - 2018年美国国家健康和营养检查调查(NHANES)的队列研究。
Front Nutr. 2025 Apr 23;12:1530025. doi: 10.3389/fnut.2025.1530025. eCollection 2025.
2
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.绝经后女性的代谢功能障碍相关脂肪性肝病:患病率、发病机制及基于性别的治疗方法
Biomedicines. 2025 Apr 2;13(4):855. doi: 10.3390/biomedicines13040855.
3
Risk factor analysis and predictive model construction of lean MAFLD: a cross-sectional study of a health check-up population in China.

本文引用的文献

1
High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men.高性激素结合球蛋白浓度是中年日本男性肝纤维化 4 指数升高的一个危险因素。
Endocr J. 2019 Jul 28;66(7):637-645. doi: 10.1507/endocrj.EJ18-0505. Epub 2019 May 9.
2
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.美国老年人中非酒精性脂肪性肝病的患病率及其长期转归。
BMC Gastroenterol. 2019 Apr 16;19(1):56. doi: 10.1186/s12876-019-0972-6.
3
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.
非酒精性脂肪性肝病(MAFLD)消瘦型的危险因素分析及预测模型构建:一项针对中国健康体检人群的横断面研究
Eur J Med Res. 2025 Feb 25;30(1):137. doi: 10.1186/s40001-025-02373-1.
4
Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD.肝脏雌激素受体α过表达可预防肝脏胰岛素抵抗和代谢相关脂肪性肝病。
Pathophysiology. 2025 Jan 3;32(1):1. doi: 10.3390/pathophysiology32010001.
5
Clinical Characteristics, Risk Factors, and Predictors of Nonobese Fatty Liver Disease: A Cross-Sectional Study.非肥胖型脂肪肝的临床特征、危险因素及预测因素:一项横断面研究
Diabetes Metab Syndr Obes. 2024 Nov 25;17:4397-4406. doi: 10.2147/DMSO.S482638. eCollection 2024.
6
The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective.Clínica Universidad de Navarra-Body Adiposity Estimator 指数是一种用于筛查代谢功能障碍相关脂肪性肝病的可靠工具:从性别角度的分析。
Lipids Health Dis. 2024 Sep 27;23(1):311. doi: 10.1186/s12944-024-02299-3.
7
Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis.基于机器学习整合的分析,通过生物信息学分析确定非酒精性脂肪性肝病中炎症与免疫反应之间的交联。
Heliyon. 2024 Jun 29;10(14):e32783. doi: 10.1016/j.heliyon.2024.e32783. eCollection 2024 Jul 30.
8
Update in lean metabolic dysfunction-associated steatotic liver disease.瘦素代谢功能障碍相关脂肪性肝病的最新进展。
World J Hepatol. 2024 Mar 27;16(3):452-464. doi: 10.4254/wjh.v16.i3.452.
9
HbA1c of 5.8% or higher as the most useful indicator for recommendation of ultrasonography to detect nonalcoholic fatty liver disease.糖化血红蛋白(HbA1c)水平达到5.8%或更高,是推荐进行超声检查以检测非酒精性脂肪性肝病的最有用指标。
JGH Open. 2023 Dec 11;7(12):990-997. doi: 10.1002/jgh3.13019. eCollection 2023 Dec.
10
Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals.认知功能未受损个体中非酒精性脂肪性肝病与β-淀粉样蛋白之间的性别特异性关系。
Front Aging Neurosci. 2023 Oct 13;15:1277392. doi: 10.3389/fnagi.2023.1277392. eCollection 2023.
非酒精性脂肪性肝病的性别差异:现状与研究空白的识别。
Hepatology. 2019 Oct;70(4):1457-1469. doi: 10.1002/hep.30626. Epub 2019 Sep 23.
4
Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation.肝细胞癌中的性别差异:非酒精性脂肪性肝病/脂肪性肝炎及肝移植方面的差异
Hepatoma Res. 2018;4. doi: 10.20517/2394-5079.2018.87. Epub 2018 Oct 18.
5
Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign.日本瘦型非酒精性脂肪性肝炎患者的特征:并非少见且并非总是良性。
J Gastroenterol Hepatol. 2019 Aug;34(8):1404-1410. doi: 10.1111/jgh.14585. Epub 2019 Jan 15.
6
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.日本全国范围内非乙型、非丙型肝细胞癌的调查:2011-2015 年更新。
J Gastroenterol. 2019 Apr;54(4):367-376. doi: 10.1007/s00535-018-1532-5. Epub 2018 Nov 29.
7
Epidemiology and Management of Hepatocellular Carcinoma.原发性肝癌的流行病学和管理。
Gastroenterology. 2019 Jan;156(2):477-491.e1. doi: 10.1053/j.gastro.2018.08.065. Epub 2018 Oct 24.
8
Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.非肥胖非酒精性脂肪性肝病中非酒精性肝炎和显著纤维化的预测因素。
Liver Int. 2019 Feb;39(2):332-341. doi: 10.1111/liv.13983. Epub 2018 Oct 27.
9
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的肝细胞癌风险。
Gastroenterology. 2018 Dec;155(6):1828-1837.e2. doi: 10.1053/j.gastro.2018.08.024. Epub 2018 Aug 23.
10
Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.系统评价与荟萃分析:非酒精性脂肪性肝炎且无肝硬化与其他肝病相比发生肝细胞癌的风险。
Aliment Pharmacol Ther. 2018 Oct;48(7):696-703. doi: 10.1111/apt.14937. Epub 2018 Aug 22.